European Patients Forum, logo.

Join us for the EPF Congress 2025!

Shaping the Future of Healthcare: Preparedness for Health Systems' Resilience
 

Amplifying Patient Advocacy on Antimicrobial Resistance (AMR)

Understanding Antimicrobial Resistance (AMR) and its impact on patients. The AMR Info Point is dedicated to providing extensive resources on AMR. Our goal is to improve awareness and understanding of AMR among patient communities.

HTA Info Point

Patient Involvement in Health Technology Assessment (HTA)

Health Technology Assessment (HTA) is a systematic evaluation process used to assess the properties, effects, and impacts of health technology. This includes not just medical devices and equipment, but also drugs, medical procedures, and broader healthcare policies and systems.

Knowledge Hub on Artificial Intelligence in Healthcare

The AI Knowledge Hub is dedicated to help patient organisations and other interested stakeholders to better engage in debates, projects and initiatives on AI in healthcare, both at national and European levels.

WHAT WE DO

Policy and advocacy, icon

Policy and advocacy

EPF is active in a number of policy areas to ensure that patients' views are incorporated into the EU policy agenda. We develop campaign and advocacy strategies

Projects icon

Projects

EPF has been active in various health-related EU projects over the past few years both as a leader or associate partner to gather patient-related evidence based information

Capacity building icon

Capacity building

The Capacity Building Programme was designed in 2012 to respond to needs and concerns which have been identified by our membership during previous activities of EPF.

NEWS AND UPDATES

07/10/25

EPF and EURORDIS Issue Joint Statement

No Future for Pharma Without Patients at the Table

25/09/25

Recommendations for the ongoing Trilogues on the revision of the EU pharmaceutical legislation

The European Patients’ Forum (EPF) has released its recommendations for the ongoing Trilogues on the revision of the EU pharmaceutical legislation. As the EU institutions engage in trilateral discussions, it is crucial for EPF to convey the patient

23/09/25

Position on the report of MEP Sokol on the Critical Medicines Act (CMA)

The European Patients’ Forum (EPF) welcomes the publication of the report of MEP Sokol (EPP, Croatia) on the Critical Medicines Act (CMA).

Visit the newspage

Upcoming events

Visit the Events page

Interested in becoming a member?

As your advocate, EPF provides many benefits to its members. We represent our members' voice at the European level on cross-cutting health issues.

Our team